Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Postgraduate Medical Journal
|
March 1, 1977
The different effects of sodium bicarbonate and aluminium hydroxide on the absorption of indomethacin in man
J C Garnham, T Kaspi, C M Kaye, et al.
American Heart Journal
|
May 1, 1985
Acebutolol: ten years of experience
G De Bono, C M Kaye, E Roland, et al.
European Journal of Clinical Pharmacology
|
August 17, 1977
An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade
C R Kumana, C M Kaye, M Leighton, et al.
British Journal of Clinical Pharmacology
|
March 29, 2012
The influence of urinary pH on the elimination of mexiletine
M A Kiddie, C M Kaye, P Turner, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1976
Observations on the pharmacokinetics of acebutolol
C M Kaye, C R Kumana, M Leighton, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1983
Concentration of metronidazole and its major metabolites in continuous ambulatory peritoneal dialysate
A Bush, J Holt, M G Sankey, et al.
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1989
Paroxetine plasma levels: lack of correlation with efficacy or adverse events
T C Tasker, C M Kaye, B D Zussman, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 1986
Metronidazole metabolism following oral benzoylmetronidazole suspension in children with giardiasis
M A Homeida, T K Daneshmend, H M Ali, et al.
Lancet (London, England)
|
July 19, 1975
Cardiac and pulmonary effects of acebutolol
C R Kumana, C M Kaye, M Leighton, et al.
British Medical Journal
|
November 23, 1974
New approach to assessment of cardioselectivity of beta-blocking drugs
C R Kumana, G E Marlin, C M Kaye, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Postgraduate Medical Journal
|
March 1, 1977
The different effects of sodium bicarbonate and aluminium hydroxide on the absorption of indomethacin in man
J C Garnham, T Kaspi, C M Kaye, et al.
American Heart Journal
|
May 1, 1985
Acebutolol: ten years of experience
G De Bono, C M Kaye, E Roland, et al.
European Journal of Clinical Pharmacology
|
August 17, 1977
An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade
C R Kumana, C M Kaye, M Leighton, et al.
British Journal of Clinical Pharmacology
|
March 29, 2012
The influence of urinary pH on the elimination of mexiletine
M A Kiddie, C M Kaye, P Turner, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1976
Observations on the pharmacokinetics of acebutolol
C M Kaye, C R Kumana, M Leighton, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1983
Concentration of metronidazole and its major metabolites in continuous ambulatory peritoneal dialysate
A Bush, J Holt, M G Sankey, et al.
Acta Psychiatrica Scandinavica. Supplementum
|
January 1, 1989
Paroxetine plasma levels: lack of correlation with efficacy or adverse events
T C Tasker, C M Kaye, B D Zussman, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 1986
Metronidazole metabolism following oral benzoylmetronidazole suspension in children with giardiasis
M A Homeida, T K Daneshmend, H M Ali, et al.
Lancet (London, England)
|
July 19, 1975
Cardiac and pulmonary effects of acebutolol
C R Kumana, C M Kaye, M Leighton, et al.
British Medical Journal
|
November 23, 1974
New approach to assessment of cardioselectivity of beta-blocking drugs
C R Kumana, G E Marlin, C M Kaye, et al.
Page
of 7